A clinical study of decreased bone density in the patients treated with long term luteinizing hormone releasing hormone analogue (LHRH-a) - The risk of iatrogenic osteoporosis due to treatment of carcinoma of prostate -

Japanese Journal of Urology

Volumn 89, Issue 12, 1998, Pages 961-966

  Suzuki, Yasuyuki ^a   Aikawa, Ken ^a   Oishi, Yukihiko ^b   Yamazaki, Haruki ^b   Onishi, Tetsuro ^b   Suzuki, Masayasu ^b   Kobari, Toshihiko ^b   Endo, Katsuhisa ^b   Yanada, Shuichi ^b   Kato, Nobuki ^b   Yoshino, Yasumasa ^b   Wada, Tetsuro ^c   Ueda, Masatake ^c   Takasaka, Satoshi ^d   Akazawa, Kouhei ^e  

^a HOSHI GENERAL HOSPITAL   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Fuji Civilian Central Hospital   (Japan)

^d Tokyo Rehabilitation Hospital   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

LH RH analogue; Osteoporosis; Prostatic carcinoma

Indexed keywords

ANTIANDROGEN; DIETHYLSTILBESTROL; ESTROGEN; GONADORELIN DERIVATIVE; GOSERELIN; LEUPRORELIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; HUMAN; HYPOGONADISM; IATROGENIC DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PROSTATE CARCINOMA;

EID: 0010045191     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.89.961     Document Type: Article

References (23)

1. Komm, B.S., Terpening, C.M., Benz, D.J., Grame, K.A., Gallegos, A., Korc, M., Greene, G. L., O'Malley, B M. and Haussler, M.R.: Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Scienc., 241, 81-84, 1988.
2. Kasperk, C.H., Wergedal, J.E., Farley, J.R., Linkhart, T.A., Turner, R.T. and Baylik, D.J.: Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology., 124, 1576-1578, 1989.
3. Orwoll, E.S., Stribrska, L., Ramsey, E.E. and Keenan, E.J.: Androgen receptor in osteoblast-like cell lines. Calcif. Tissue. Int., 49, 183 -187, 1991.
4. Kelly, P.J., Pocock, N.A., Sambrook, P.N. and Eisman, J.A.: Dietary calcium, sex hormones, and bone mineral density in men. B.M.J., 300, 1361-1364, 1990.
5. Murphy, S., Khaw, K.T., Cassidy, A., and Compston, J.E.: Sex hormones and bone mineral density in elderly men. Bone. Miner., 20, 133-140, 1993.
6. Osteoporosis Japan, 4, 643-653, 1996.
7. Scane, A.C., Sutcliffe, A.M. and Francis, R.M.: Osteoporosis in men. Baillieres Clin. Rheumatol., 7, 589-601, 1993.
8. Microdensitometry 43, 1140-1145, 1992.
9. Therapeutic Research, 13, 649-655, 1992.
10. Daniell, H.W.: Osteoporosis after orchiectomy for prostate cancer. J. Urol., 157, 439-444, 1997.
11. Huggins, C. and Hodges, C.V.: Studies on prostate cancer. I. The effect of castration of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res., 1, 293-297, 1941.
12. Devogelaer, J.P., Nagant, de Deuxchaisnes, C., Donnenz, J. and Thomas, K.: LHRH analogues and bone loss. Lancet., 27, 1498, 1987.
13. Fraser, I.S.: Relationship between Gonadotropin-releasing hormone analogue therapy and bone loss. Reprod. Fertil. Dev., 3, 61-69, 1991.
14. Maillefert, J.F., Sibilia, J., Kuntz, J.L. and Tavernier, C.: Gonadotrophin-releasing hormone agonists induce osteoporosis. Br. J. Rheumatol., 33, 1199-1200, 1994.
15. Collinson, M.P., Tyrrel, C.J. and Hutton, C.: Osteoporosis occurring in two patients receiving LHRH analogues for carcinoma of the prostate. Calcif. Tissue. Int., 54, 327-328, 1994.
16. Townsend, M.F, Sanders, W.H., Northway, R. O. and Graham, S.D. Jr.: Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma. Cancer., 79, 545-550, 1997.
17. Cox, R.L. and Crawford, E.D.: Estrogens in the treatment of prostate cancer. J. Urol., 154, 1991-1998, 1995.